The federal government’s 340B Drug Pricing Program has been under a lot of scrutiny recently. More than 30 years old at this point, the program has significantly expanded since its inception. Now it is looking at a potential overhaul thanks to litigation, new state laws, and potential intervention by Congress. Indeed, 2024 could end up being a big year for the program.
Congress created the 340B Drug Pricing Program in 1992 to help hospitals and healthcare clinics serving the indigent stretch their federal dollars further by giving them access to deeply discounted drugs. These were mostly disproportionate share hospitals that provided a good portion of their services to the poor and needy. These days however, there is evidence that the original intent of 340B has long since been abandoned and is now used as a way to boost bottom lines.
340B Litigation in the Courts
Multiple lawsuits have been filed …
Continue reading